Why Orthopedic Groups Are Walking Away from Medicare
Independent orthopedic practices across the U.S. are reducing Medicare exposure — and in some cases dropping it entirely — as reimbursement rates fail to keep pace with rising…
Financial planning, analysis, budgeting, forecasting, and unit economics.
Independent orthopedic practices across the U.S. are reducing Medicare exposure — and in some cases dropping it entirely — as reimbursement rates fail to keep pace with rising…
Health systems in 2026 are applying a “buy, sell, or fight” calculus to market strategy — acquiring where they can build density, divesting where they’re subscale, and competing…
Enhanced ACA premium subsidies expired at the end of 2025, and major health systems are now reporting the financial fallout in Q1 earnings. HCA Healthcare saw a 15%…
Over 80 million Americans lack dental insurance — and many are already patients at DSO-affiliated practices. Dental membership programs convert uninsured patients into recurring revenue by bundling preventive…
Becker’s Hospital Review is tracking 21 health systems that have terminated or are exiting Medicare Advantage contracts in 2026, citing persistent prior authorization denials and inadequate reimbursement from…
Universal Health Services reported Q1 2026 volume declines in both its acute care and behavioral health divisions, driven by a weak respiratory season and winter storms. Despite the…
Both health systems and health insurers privately acknowledge that AI ambient scribes are driving up healthcare costs — though they frame the issue very differently. Providers argue scribes…
PwC’s 2026 healthcare investment outlook projects a more consistent year for private equity deal activity, supported by lower interest rates, available dry powder, and LP pressure for liquidity…
ADA’s Q1 2026 data show dentist confidence holding steady, but the underlying economics are under pressure: reimbursement rates are flat while supply and wage costs are rising. Roughly…
PwC analysts note that total 2025 deal value dropped to $46B, but Q4 activity rebounded. For 2026, the focus will be on bolt-on acquisitions and carve-outs rather than…